title: Vulvodynia.
abstract: Vulvodynia is a genital pain syndrome occurring in 7% to 8% of women. Although common, most practitioners are uncomfortable with the diagnosis and management of these women's pain, and many believe this is psychologically based. Multifactorial in origin, ubiquitous factors include pelvic floor muscle abnormalities, neuropathic pain, anxiety, and primary or secondary sexual dysfunction. Although there are many published studies on vulvodynia, quality trials that evaluate therapy are lacking. However, experience suggests that most patients are significantly improved with pelvic floor physical therapy, medication for neuropathic pain, psychological support, and attention to sexual function.
authors.affiliation: Carolinas Medical Center, Charlotte, North Carolina.
authors.forename: Libby
authors.initials: L
authors.lastname: Edwards
mesh_terms: D000279:Administration, Cutaneous; D000588:Amines / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D000779:Anesthetics, Local / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D004414:Dyspareunia / Q000150:complications; D005260:Female; D000077206:Gabapentin; D006801:Humans; D009407:Nerve Block; D010353:Patient Education as Topic; D026741:Physical Therapy Modalities; D000069583:Pregabalin; D056650:Vulvodynia / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
chemical_list: D000588:Amines; D000700:Analgesics; D000779:Anesthetics, Local; D000928:Antidepressive Agents; D003509:Cyclohexanecarboxylic Acids; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin